In the past few years, accumulating evidence was provided sustaining a direct genetic link between GBA1 homo- and heterozygous mutations and increased incidence of synucleinopathies, including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) [1,2,3,4]. The gene discussed is GBA1; the disease is Lewy body dementia.